Cumberland Pharmaceuticals CPIX Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's finished goods?
- Cumberland Pharmaceuticals (CPIX) reported finished goods of $5.27M in Q1 2026.
- How has Cumberland Pharmaceuticals's finished goods changed year-over-year?
- Cumberland Pharmaceuticals's finished goods increased by 75.1% year-over-year, from $3.01M to $5.27M.
- What is the long-term trend for Cumberland Pharmaceuticals's finished goods?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's finished goods has grown at a -1.0% compound annual growth rate (CAGR), from $5.94M to $5.65M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.